Global Pharmaceuticals & Biotech Stable Growth Stocks

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥43.6b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

3SBio

Market Cap: HK$41.1b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

Chugai Pharmaceutical

Market Cap: JP¥11.7t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

PharmaResearch

Market Cap: ₩4.3t

Operates as a biopharmaceutical company primarily in South Korea.

Orion Oyj

Market Cap: €11.1b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Incyte

Market Cap: US$25.0b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

PharmaEssentia

Market Cap: NT$569.8b

A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.

Ajanta Pharma

Market Cap: ₹457.1b

A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.

Emcure Pharmaceuticals

Market Cap: ₹356.7b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

Neuland Laboratories

Market Cap: ₹302.3b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

Samsung BiologicsLtd

Market Cap: ₩72.8t

Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.

Acutaas Chemicals

Market Cap: ₹262.8b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

WuXi AppTec

Market Cap: CN¥497.6b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.

Shenyang Xingqi PharmaceuticalLtd

Market Cap: CN¥14.6b

Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.

ACADIA Pharmaceuticals

Market Cap: US$5.2b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

Exelixis

Market Cap: US$13.2b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Jiangsu Hengrui PharmaceuticalsLtd

Market Cap: CN¥325.9b

A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.

AstraZeneca

Market Cap: UK£186.9b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

CareDx

Market Cap: US$2.4b

Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

Kiniksa Pharmaceuticals International

Market Cap: US$6.2b

A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.

HitGen

Market Cap: CN¥15.5b

Operates as a drug discovery research platform for small molecules and nucleic acid drugs in China and internationally.

Hanmi Pharm

Market Cap: ₩5.1t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

Rubicon Research

Market Cap: ₹291.4b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

Zhejiang Wolwo Bio-Pharmaceutical

Market Cap: CN¥13.6b

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Sumitomo Pharma

Market Cap: JP¥657.2b

Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.

Galderma Group

Market Cap: CHF 39.9b

Operates as a dermatology company worldwide.

Neurocrine Biosciences

Market Cap: US$15.7b

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.

Agilent Technologies

Market Cap: US$41.9b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Granules India

Market Cap: ₹208.6b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.

Kyowa Kirin

Market Cap: JP¥1.4t

Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.

Hansoh Pharmaceutical Group

Market Cap: HK$204.2b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

Astellas Pharma

Market Cap: JP¥4.3t

Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

UCB

Market Cap: €41.5b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

IQVIA Holdings

Market Cap: US$39.5b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Vertex Pharmaceuticals

Market Cap: US$133.9b

Operates as a biotechnology company in the United States, Europe, and internationally.

Eli Lilly

Market Cap: US$1.1t

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.